Results 111 to 120 of about 1,495 (185)
A Review of Senolytic Drugs in Reducing the Biological Problems of Aging [PDF]
Objectives Considering the increase in the old adult population and age-related disorders, there is a need for strategies to reduce the complications of aging.
Sara Assadiasl +2 more
doaj
Background Senescence in stem cells and progenitor cells can be particularly detrimental because these cells are essential for tissue renewal and overall organismal homeostasis.
Valeria Mazzone +7 more
doaj +1 more source
Osteosarcoma (OS) is a type of bone tumour characterized by high risk of metastatic progression and recurrence after therapy. Traditional tumour treatment methods such as radiotherapy and chemotherapy can lead to the accumulation of senescent cells in ...
Xianlin Yue +8 more
doaj +1 more source
SGLT2 regulates immune-mediated senolysis
Guangran Guo, Corina Amor
openaire +2 more sources
Systemic Senolysis in Naturally Aged Mice Using a FAST-PLV Gene Therapy Approach
Abstract Approaches to eliminate senescent cells in vivo using transgenic mouse models have demonstrated significant improvements in lifespan, reduction in cancer incidence, and amelioration of age-related degeneration. These approaches require, however, that the organism be genetically engineered from the embryo and/or repeatedly dosed for the
John Lewis +17 more
openaire +1 more source
Immunosuppressive macrophages determine the effect of cellular senescence on tumor progression. [PDF]
Lalinde-Gutiérrez M +9 more
europepmc +1 more source
1444 Senolysis is needed for the clearance of senescent tumor cells [PDF]
K. Böhm, M. Röcken
openaire +1 more source
Mitochondrial bioenergetics-SASP crosstalk determines senolytic efficacy in therapy-induced senescence. [PDF]
Llop-Hernández À +5 more
europepmc +1 more source
Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance. [PDF]
Wakita M +14 more
europepmc +1 more source
Cellular senescence in lung cancer immune microenvironment and senotherapeutic opportunities. [PDF]
Xu Z, Liu F, Huang S, Chu Q.
europepmc +1 more source

